On Monday, Ventyx Biosciences Inc (NASDAQ: VTYX) opened lower -5.63% from the last session, before settling in for the closing price of $2.31. Price fluctuations for VTYX have ranged from $1.79 to $36.19 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 34.70% at the time writing. With a float of $54.69 million, this company’s outstanding shares have now reached $59.24 million.
Considering the fact that the conglomerate employs 80 people, you should pay attention to its efficiency factor.
Ventyx Biosciences Inc (VTYX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ventyx Biosciences Inc is 22.62%, while institutional ownership is 71.59%. The most recent insider transaction that took place on Apr 02 ’24, was worth 8,921. In this transaction CHIEF BUSINESS OFFICER of this company sold 1,651 shares at a rate of $5.40, taking the stock ownership to the 284,999 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 264,998 shares in total.
Ventyx Biosciences Inc (VTYX) Recent Fiscal highlights
#####
According to the Wall Street analysts, stocks earnings will be around 34.70% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Check out the current performance indicators for Ventyx Biosciences Inc (VTYX). In the past quarter, the stock posted a quick ratio of 14.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.79, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.22 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Compared to the last year’s volume of 2.25 million, its volume of 1.47 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 12.67%. Additionally, its Average True Range was 0.17.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 10.08%, which indicates a significant decrease from 14.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.48% in the past 14 days, which was lower than the 115.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.24, while its 200-day Moving Average is $3.58. Nevertheless, the first resistance level for the watch stands at $2.29 in the near term. At $2.41, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.48. If the price goes on to break the first support level at $2.11, it is likely to go to the next support level at $2.04. Now, if the price goes above the second support level, the third support stands at $1.93.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are currently 70,499K shares outstanding in the company with a market cap of 154.06 million. Presently, the company’s annual sales total 0 K according to its annual income of -192,960 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -31,950 K.
